SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-16-011842
Filing Date
2016-02-26
Accepted
2016-02-26 16:28:01
Documents
4
Period of Report
2016-02-26
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A PCRX 2-26-16 pcrx8-kafeb262016.htm 8-K 32587
2 EXHIBIT 16.1 exhibit161pcrx2-26x16.htm EX-16.1 3891
3 cohnreznicka02.jpg GRAPHIC 35564
4 crsiga02.jpg GRAPHIC 10849
  Complete submission text file 0001628280-16-011842.txt   101925
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 161462305
SIC: 2834 Pharmaceutical Preparations